FOSUN PHARMA (02196.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec10

Fosun Pharmaceutical's subsidiary's Foscarnet Sodium Injection drug registration application approved by NMPA

08:53

Fosun Pharma Signs License Agreement with Pfizer for YP05002 Weight Loss Pill

02:11

Dec9

Dual-track System of National Health Insurance and Commercial Health Insurance for Mutual Benefit

20:07

Fosun Pharma's Subsidiary Signs Global License Agreement with Pfizer for GLP-1R Agonist

10:51

Dec7

Fosun Pharma's Multiple Products Included in 2025 National Health Insurance Catalog

07:43

Rare Disease Drugs Included in the 2025 Medical Insurance and Commercial Health Insurance Innovative Drug Catalogue

04:09

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 10.8 B, Net Income 897.85 M, EPS 0.3388

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 11.05 B, Net Income 1.026 B, EPS 0.3825

Aug22

Distribution Plan(CST)

Cash dividend 0.35 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More